MindAffect logo — BCI/AI HealthTech Innovations for diagnostics and communicat...

MindAffect

BCI/AI HealthTech Innovations for diagnostics and communication

Founded 2017 The Netherlands The Netherlands 16 employees Series A Total: $1.48M AI, IT

General Information

Company Name MindAffect
Founded Year 2017
Location The Netherlands The Netherlands +2
Employees 16
Industries AI, IT
Funding Stage Series A
Social

Get notified when MindAffect moves

Funding, new markets, leadership changes, hiring surges — one e-mail, only when something happens.

Free · no account needed

Recorded by Bounce Watch from public sources. Every entry below carries the date we observed it, and when we have not looked recently the page says so rather than leaving silence to imply nothing happened.

Tech Stack Change Aug 27, 2026

Started running email through Google Workspace.

Event Participation Aug 19, 2026

MindAffect is participating as an exhibitor and speaker at IFOS2026, an event taking place in Istanbul from September 9-13, 2026.

AI Insight

Bounce Watch AI
2 months ago

MindAffect is actively pursuing a strategy of global expansion and market validation through strategic partnerships, evidenced by recent collaboration discussions with Barcelona Children's Hospital Sant Joan de Déu. Furthermore, the company has formalized an MoU with key Cambodian entities for audiology research and training. These developments underscore a clear push towards leveraging international collaborations for broader adoption and research in neurosensory diagnostics.

Signal Types
Partnership Business Development Expansion
Strategic Labels
International Expansion Strategic Partnerships Market Validation
Next Move: Fundraising
·
Impact: 8/10
·
Ideal For: HealthTech VCs — Series A/B

About MindAffect

MindAffect, founded in 2017, is at the cutting edge of BCI/AI HealthTech Innovations for diagnostics and communication. Specializing in both AI and IT sectors, this The Netherlands-based neuroscience healthtech company focuses on developing advanced hearing and vision diagnostic systems.

Marking a significant milestone, MindAffect recently secured a €230.00K Series A investment in June 2024 from Health Venture. This financial endorsement underscores investor confidence in their potential to revolutionize diagnostic technology.

With its innovative approach and a promising position in the healthtech industry, MindAffect presents a compelling opportunity for investors seeking to tap into the burgeoning intersection of AI and healthcare solutions.

Taxonomy: BCI, AI HealthTech, Neuroscience, Hearing Diagnostics, Vision Diagnostics, Neural Circuit Testing, Human Communication, EEG Analysis, EMG Signals, Neurotech, Hearing Technology, Vision Technology, Diagnostics Systems, Signal Processing

Services & Products

Development of Sensory Assessment Solutions
Objective Hearing Assessment Systems
Vision Assessment Tools
AI/BCI Platform for Sensory Diagnostics

Target Customers

Medical Institutions Audiologists Ophthalmologists Neurologists Healthcare Providers

Funding Rounds & Investors (6)

View All
Funding Stage Amount Investors Lead Investors Date
Series A •••••• 1
Investor
01 Jun 2024
Seed •••••• 1
Investor
01 Feb 2020
Support Program •••••• 1 •••• •••• 01 Jul 2019
Seed •••••• 1
Investor
01 May 2018
Seed •••••• 1
Investor
01 Sep 2017

View All 6 Funding Rounds

MindAffect Alternatives & Competitors

View All Alternatives
MindAffect vs

Making every breath count with our revolutionary RespiraSense continuous respiratory rate monitoring...

Non Equity Assistance
27 employees
Biotechnology, Health Care
MindAffect vs
DNANUDGE
DNANUDGE United Kingdom

Nudging your everyday choices through your DNA plus your lifestyle. Buy in-store and online now.

Series A
38 employees
Health Care
MindAffect vs
Predikta
Predikta Brazil

A nova fronteira da medicina diagnóstica! Sinais e sintomas inteligentes! Aprovada pela ANVISA

6 employees
AI, Computing

FAQ About MindAffect

BCI/AI HealthTech Innovations for diagnostics and communication
MindAffect was founded in 2017.
MindAffect is headquartered in The Netherlands.
MindAffect operates in the following industries: AI, IT.
MindAffect has approximately 16 employees.
MindAffect has completed 6 funding rounds, raising a total of $1.48M. The latest funding stage is Series A.
MindAffect offers: Development of Sensory Assessment Solutions, Objective Hearing Assessment Systems, Vision Assessment Tools, AI/BCI Platform for Sensory Diagnostics.
Top alternatives and competitors to MindAffect include PMD Solutions, DNANUDGE, Predikta, Presagen, AccurKardia. These companies operate in related industries and serve comparable markets. You can compare them side by side on Bounce Watch.
MindAffect and PMD Solutions are both companies in similar industries. Compare their funding, team size, growth signals, and market position on Bounce Watch to see which one fits your needs.

Don't just browse. Track.

Signal Tracker monitors MindAffect and millions of companies for funding rounds, hiring surges, product changes, and 40+ signal types — so you never miss an opportunity.

One analytics cookie (Google Analytics). Cookie Policy